Semaglutide may contribute to hair loss through rapid weight loss, nutrient deficiencies, or hormonal changes
GLP-1 medications and structured medical weight loss are appropriate for adults with: BMI of 30 or higher, OR BMI of 27+ with at least one weight-related condition (diabetes, prediabetes, hypertension, sleep apnea, fatty liver) Type 2 diabetes (Ozempic, Mounjaro, Trulicity) Documented difficulty losing weight through lifestyle alone Our weight loss program is built for long-term results, not crash outcomes: GLP-1 receptor agonists: semaglutide (Wegovy), liraglutide (Saxenda) Dual GIP/GLP-1 agonists: tirzepatide (Zepbound, Mounjaro) Other FDA-approved weight loss medications when appropriate An honest discussion of medication options and costs up front Nutrition guidance focused on protein and muscle preservation Lab monitoring and side effect management A realistic plan for staying off the medication eventually, or staying on safely 03 Why a primary care provider matters GLP-1 medications affect blood sugar, blood pressure, kidney function, and gallbladder health, interact with other medications, and have side effects that need active management
AOD-9604 operates through the beta-3 adrenergic pathway independent of the IGF-1 axis and GHRH pathway, making it a clean independent variable alongside IGF-1 LR3 or GHRH analogues like CJC-1295 and tesamorelin in multi-compound research designs
This guide explains the nutritional considerations, timing factors, and best practices for eating bananas during semaglutide therapy
Is 2.5mg tirzepatide strong enough to cause weight loss, or is it just a starter dose
